---
figid: PMC10028837__nihpp-2023.03.03.530734v1-f0009
figtitle: Suggested model for VraFG-dependent high-level Beta-lactam resistance in
  the MRSA pgl mutant
organisms:
- Staphylococcus aureus
- Staphylococcus epidermidis
- Bacillus subtilis
- Listeria monocytogenes
- Severe acute respiratory syndrome coronavirus 2
- Colocasia esculenta
- Staphylococcus aureus subsp. aureus RN4220
- Escherichia coli
- Meleagris gallopavo
- Homo sapiens
- NA
organisms_ner:
- Staphylococcus epidermidis
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC10028837
filename: nihpp-2023.03.03.530734v1-f0009.jpg
figlink: /pmc/articles/PMC10028837/figure/F9/
number: F9
caption: A. Illustration of JE2 and pgl cell division during growth in CDMG OX. pgl
  cells are smaller than wild-type JE2 when grown in CDMG and undergo normal cell
  division, whereas extensive lysis is evident among wild type cells. B. Illustration
  of peptidoglycan (PG), wall teichoic acid (WTA) and lipoteichoic acid (LTA) biosynthesis
  in a pgl mutant. Mutations in vraF, vraG and to a lesser extent graR reverse the
  increased OX resistance phenotype of the pgl mutant. Metabolic reprogramming in
  the pgl mutant increases carbon flux to cell envelope precursors and β-lactam resistance
  via a mechanism dependent on VraFG/GraRS-controlled regulation of WTA/LTA biosynthesis,
  export or posttranslational modification. Previous studies have implicated the VraFG/GraRS
  complex in resistance to cationic antimicrobial peptides and regulation of dltABCD
  and mprF transcription, and it has also been proposed to play a role in the export
  of peptidoglycan or teichoic acid precursors or modifying subunits.
papertitle: Metabolic reprogramming and flux to cell envelope precursors in a pentose
  phosphate pathway mutant increases MRSA resistance to β-lactam antibiotics.
reftext: Merve S. Zeden, et al. bioRxiv. 2023 Mar 7:2023.03.03.530734.
year: '2023'
doi: 10.1101/2023.03.03.530734
journal_title: bioRxiv
journal_nlm_ta: bioRxiv
publisher_name: Cold Spring Harbor Laboratory
keywords: MRSA | methicillin resistance | metabolism | pentose phosphate pathway |
  Pgl | 6-phosphogluconolactonase | cell morphology
automl_pathway: 0.5716095
figid_alias: PMC10028837__F9
figtype: Figure
redirect_from: /figures/PMC10028837__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10028837__nihpp-2023.03.03.530734v1-f0009.html
  '@type': Dataset
  description: A. Illustration of JE2 and pgl cell division during growth in CDMG
    OX. pgl cells are smaller than wild-type JE2 when grown in CDMG and undergo normal
    cell division, whereas extensive lysis is evident among wild type cells. B. Illustration
    of peptidoglycan (PG), wall teichoic acid (WTA) and lipoteichoic acid (LTA) biosynthesis
    in a pgl mutant. Mutations in vraF, vraG and to a lesser extent graR reverse the
    increased OX resistance phenotype of the pgl mutant. Metabolic reprogramming in
    the pgl mutant increases carbon flux to cell envelope precursors and β-lactam
    resistance via a mechanism dependent on VraFG/GraRS-controlled regulation of WTA/LTA
    biosynthesis, export or posttranslational modification. Previous studies have
    implicated the VraFG/GraRS complex in resistance to cationic antimicrobial peptides
    and regulation of dltABCD and mprF transcription, and it has also been proposed
    to play a role in the export of peptidoglycan or teichoic acid precursors or modifying
    subunits.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - vraG
  - graS
  - vraF
  - graR
  - mprF
  - ltaS
  - SDHD
  - DOCK3
  - PEBP1
  - PKD1
  - MED1
  - PPBP
  - TARS1
  - TARP
  - TRGC1
  - TRIOBP
  - LTA
  - ox
  - Lcp65Aa
  - ThrRS
  - tara
  - oo
---
